UK Markets closed

The Renalytix share price – where next?

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

The Renalytix (LON:RENX) share price has risen by 6.25% over the past month and it’s currently trading at 170p. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.

According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, Renalytix currently has:

  • 2 Buy recommendations

  • 1 Hold recommendations

  • 0 Sell recommendations

This suggests that analysts are generally positive about the outlook.

GET MORE DATA-DRIVEN INSIGHTS INTO LON:RENX »

Going beyond analyst recommendations

At its current price of 170p, shares in Renalytix are trading at a discount of -85.7% to its 52 week high price. The 1-year performance of the shares has been -84.6%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Renalytix it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Renalytix that you can find out about here.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting